A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.

AIMS Bacterial inclusion bodies (IBs) are protein-based, amyloidal nanomaterials that mechanically stimulate mammalian cell proliferation upon surface decoration. However, their biological performance as potentially functional scaffolds in mammalian cell culture still needs to be explored. MATERIALS & METHODS Using fluorescent proteins, we demonstrate significant membrane penetration of surface-attached IBs and a corresponding intracellular bioavailability of the protein material. RESULTS When IBs are formed by protein drugs, such as the intracellular acting human chaperone Hsp70 or the extracellular/intracellular acting human FGF-2, IB components intervene on top-growing cells, namely by rescuing them from chemically induced apoptosis or by stimulating cell division under serum starvation, respectively. Protein release from IBs seems to mechanistically mimic the sustained secretion of protein hormones from amyloid-like secretory granules in higher organisms. CONCLUSION We propose bacterial IBs as biomimetic nanostructured scaffolds (bioscaffolds) suitable for tissue engineering that, while acting as adhesive materials, partially disintegrate for the slow release of their biologically active building blocks. The bottom-up delivery of protein drugs mediated by bioscaffolds offers a highly promising platform for emerging applications in regenerative medicine.

[1]  Antonio Villaverde,et al.  Nanostructured bacterial materials for innovative medicines. , 2010, Trends in microbiology.

[2]  Vladka Gaberc-Porekar,et al.  Engineering inclusion bodies for non denaturing extraction of functional proteins , 2008, Microbial cell factories.

[3]  A. Villaverde,et al.  Protein quality in bacterial inclusion bodies. , 2006, Trends in biotechnology.

[4]  H. Cha,et al.  Development of bioadhesives from marine mussels , 2008, Biotechnology journal.

[5]  A. Villaverde,et al.  Amyloid-like properties of bacterial inclusion bodies. , 2005, Journal of molecular biology.

[6]  F. Amalric,et al.  Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  A. Villaverde,et al.  Protein aggregation in recombinant bacteria: biological role of inclusion bodies , 2003, Biotechnology Letters.

[8]  E. Vázquez,et al.  Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine , 2011, Microbial cell factories.

[9]  Eric Vives,et al.  Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.

[10]  R. Riek,et al.  Amyloid as a Depot for the Formulation of Long-Acting Drugs , 2008, PLoS biology.

[11]  R. Zernicke,et al.  Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. , 2009, Molecular pharmaceutics.

[12]  A. Fink,et al.  Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR. , 1994, Biochemistry.

[13]  Xia Zhao,et al.  Induction of cell migration in vitro by an electrospun PDGF-BB/PLGA/PEG-PLA nanofibrous scaffold. , 2011, Journal of biomedical nanotechnology.

[14]  Antonio Villaverde,et al.  Learning about protein solubility from bacterial inclusion bodies , 2009, Microbial cell factories.

[15]  R. Komel,et al.  Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells , 2010, Microbial cell factories.

[16]  S. Doglia,et al.  In situ protein folding and activation in bacterial inclusion bodies. , 2008, Biotechnology and bioengineering.

[17]  A. Villaverde,et al.  Divergent genetic control of protein solubility and conformational quality in Escherichia coli. , 2007, Journal of molecular biology.

[18]  U. Rinas,et al.  Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies , 2012, Advanced materials.

[19]  A. Villaverde,et al.  Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins , 2005, Microbial cell factories.

[20]  R. Komel,et al.  Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells , 2012, Microbial Cell Factories.

[21]  R. Sabaté,et al.  Amyloids in bacterial inclusion bodies. , 2009, Trends in biochemical sciences.

[22]  A. Villaverde,et al.  Co-production of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control , 2011, Microbial cell factories.

[23]  J. Karp,et al.  Scaffolds for Tissue Engineering , 2003 .

[24]  Jae Min Lim,et al.  The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture. , 2009, Biomaterials.

[25]  J. Veciana,et al.  Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering. , 2012, Nanomedicine.

[26]  Antonio Villaverde,et al.  Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. , 2013, Biotechnology advances.

[27]  J. Veciana,et al.  Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial , 2009 .

[28]  A. Villaverde,et al.  The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures , 2007, Biotechnology and bioengineering.

[29]  Zhanglin Lin,et al.  Small surfactant-like peptides can drive soluble proteins into active aggregates , 2012, Microbial Cell Factories.

[30]  H. Prats,et al.  Nuclear Translocation of Basic Fibroblast Growth Factor a , 1991, Annals of the New York Academy of Sciences.

[31]  Esther Vázquez,et al.  Engineering building blocks for self-assembling protein nanoparticles , 2010, Microbial cell factories.

[32]  Ana Jaklenec,et al.  Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. , 2008, Biomaterials.

[33]  Srinivas Madduri,et al.  Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. , 2010, Biomaterials.

[34]  A. Villaverde,et al.  Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. , 2007, FEMS microbiology letters.

[35]  L. Griffith,et al.  The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. , 2009, Biomaterials.

[36]  Elena García-Fruitós,et al.  Inclusion bodies: a new concept , 2010, Microbial cell factories.

[37]  David Eisenberg,et al.  In Brief , 2009, Nature Reviews Neuroscience.

[38]  C. Werner,et al.  FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. , 2010, Biomaterials.

[39]  Peter Molnar,et al.  Photolithographic Patterning of C2C12 Myotubes using Vitronectin as Growth Substrate in Serum‐Free Medium , 2007, Biotechnology progress.

[40]  Silvia Maria Doglia,et al.  Kinetics of inclusion body formation studied in intact cells by FT‐IR spectroscopy , 2005, FEBS letters.

[41]  Giancarlo Tonon,et al.  Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. , 2006, Biochimica et biophysica acta.

[42]  A. Villaverde,et al.  Friendly production of bacterial inclusion bodies , 2010 .

[43]  Esther Vázquez,et al.  Bacterial inclusion bodies: making gold from waste. , 2012, Trends in biotechnology.

[44]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[45]  Frank Hoffmann,et al.  Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale , 2004 .

[46]  R. Komel,et al.  Active Protein Aggregates Produced in Escherichia coli , 2011, International journal of molecular sciences.

[47]  F. Avilés,et al.  Inclusion bodies: specificity in their aggregation process and amyloid-like structure. , 2008, Biochimica et biophysica acta.

[48]  A. Villaverde.  Nanotechnology, bionanotechnology and microbial cell factories , 2010, Microbial cell factories.

[49]  A. Mitraki.  Protein aggregation from inclusion bodies to amyloid and biomaterials. , 2010, Advances in protein chemistry and structural biology.

[50]  E. Vázquez,et al.  Post-production protein stability: trouble beyond the cell factory , 2011, Microbial cell factories.

[51]  Matthew C. Phipps,et al.  The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. , 2008, Biomaterials.

[52]  Antonio Villaverde,et al.  Recombinant protein solubility—does more mean better? , 2007, Nature Biotechnology.

[53]  Ravi V Bellamkonda,et al.  Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. , 2008, Biomaterials.

[54]  U. Rinas,et al.  Packaging protein drugs as bacterial inclusion bodies for therapeutic applications , 2012, Microbial Cell Factories.

[55]  Antonio Villaverde,et al.  The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. , 2010, Biomaterials.

[56]  Xiaohong Li,et al.  Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels. , 2012, Acta biomaterialia.

[57]  S. Grimaldi,et al.  A Combined Synthetic-Fibrin Scaffold Supports Growth and Cardiomyogenic Commitment of Human Placental Derived Stem Cells , 2012, PloS one.

[58]  E. Vázquez,et al.  Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering , 2010, Nanotechnology.

[59]  Ehud Gazit,et al.  Amyloids: not only pathological agents but also ordered nanomaterials. , 2008, Angewandte Chemie.

[60]  A. Villaverde,et al.  Isolation of cell-free bacterial inclusion bodies , 2010, Microbial cell factories.

[61]  A. Panda,et al.  Kinetics of Inclusion Body Formation and Its Correlation with the Characteristics of Protein Aggregates in Escherichia coli , 2012, PloS one.

[62]  Zhanglin Lin,et al.  Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli , 2011, Microbial cell factories.

[63]  N. Gadegaard,et al.  Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. , 2011, Nature materials.

[64]  S. Sokic,et al.  FGF-1 and proteolytically mediated cleavage site presentation influence three-dimensional fibroblast invasion in biomimetic PEGDA hydrogels. , 2012, Acta biomaterialia.

[65]  Matthew R Chapman,et al.  Functional Amyloids Signal Their Arrival , 2009, Science Signaling.

[66]  Larry L Hench,et al.  Third-Generation Biomedical Materials , 2002, Science.

[67]  Antonio Villaverde,et al.  Localization of Functional Polypeptides in Bacterial Inclusion Bodies , 2006, Applied and Environmental Microbiology.

[68]  Solvig Diederichs,et al.  Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. , 2012, Tissue engineering. Part A.